A comparison of the cardiorespiratory effects of salbutamol and isoproterenol-phenylephrine aerosols in asthma.
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000328:Adult; D000336:Aerosols; D000605:Amino Alcohols / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000494:pharmacology; D002082:Butylamines / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007545:Isoproterenol / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010627:Phenethylamines / Q000627:therapeutic use; D010656:Phenylephrine / Q000008:administration & dosage*; D012119:Respiration / Q000187:drug effects*; D012129:Respiratory Function Tests; D013997:Time Factors; D014797:Vital Capacity / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D000605:Amino Alcohols; D001993:Bronchodilator Agents; D002082:Butylamines; D010627:Phenethylamines; D010656:Phenylephrine; D007545:Isoproterenol; D010100:Oxygen